| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |